ONCO (Onconetix) FCF Margin %: -10,100.00% (As of Mar. 2026)


ONCO Onconetix Inc ONCO
23 GF Score
Price $0.98
! 4 Warning Signs
View Full Analysis

What is Onconetix FCF Margin %?

Onconetix ONCO 23 FCF Margin % is -10,100.00% as of Mar. 2026. GuruFocus rates ONCO with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Onconetix ranks worse than 81.02% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Onconetix's Free Cash Flow for the three months ended in Mar. 2026 was $-2.12 Mil. Onconetix's Revenue for the three months ended in Mar. 2026 was $0.02 Mil. Therefore, Onconetix's FCF Margin % for the quarter that ended in Mar. 2026 was -10,100.00%.

As of today, Onconetix's current FCF Yield % is -270.94%.

The historical rank and industry rank for Onconetix's FCF Margin % or its related term are showing as below:

ONCO' s FCF Margin % Range Over the Past 10 Years
Min: -23510.34   Med: -1187.48   Max: -416.96
Current: -1333.33

During the past 7 years, the highest FCF Margin % of Onconetix was -416.96%. The lowest was -23510.34%. And the median was -1187.48%.

ONCO's FCF Margin % is ranked worse than
81.02% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs ONCO: -1333.33

Onconetix FCF Margin % Related Terms

Onconetix FCF Margin % Historical Data

* Premium members only.

The historical data trend for Onconetix's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onconetix FCF Margin % Chart

Onconetix Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -23,510.34 -416.96 -1,187.48

Onconetix Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,960.78 -1,330.19 -1,045.39 -1,016.78 -10,100.00

ONCO vs ISCO, VRAX, LYRA: FCF Margin % Comparison

For the Biotechnology subindustry, Onconetix's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Onconetix FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onconetix's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Onconetix's FCF Margin % falls into.


ONCO
23GF Score
Onconetix Inc ONCO
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onconetix FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Onconetix's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-9.678/0.815
=-1,187.48 %

Onconetix's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.121/0.021
=-10,100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -10,100.00% mean?
Onconetix (ONCO) has a FCF Margin % of -10,100.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Onconetix and its competitors. According to the industry distribution chart, Onconetix ranks #777 out of 959 companies in the Biotechnology industry, placing it in the top 81%.
Is Onconetix's FCF Margin % too high?
Onconetix's current FCF Margin % is -10,100.00%. Based on the distribution chart, Onconetix ranks #777 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Onconetix has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Onconetix's FCF Margin % compare to ISCO and VRAX?
According to the Biotechnology industry distribution chart, Onconetix ranks #777 out of 959 companies for FCF Margin %. This places Onconetix in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Onconetix and its competitors. Onconetix's current FCF Margin % is -10,100.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onconetix stock overvalued right now?
Onconetix (ONCO) has a current FCF Margin % of -10,100.00%. The current FCF Margin % is -10,100.00%. Onconetix's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Onconetix (ONCO), the current FCF Margin % is -10,100.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onconetix Business Description

Address 201 E. Fifth Street, Suite 1900, Cincinnati, OH, USA, 45202
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
23GF Score

Get the complete analysis for ONCO

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.98
Price